HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

4- (5- pentadecyl- 1,3,4- oxadiazol- 2- yl)pyridine

has antitubercular activity; structure in first source

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Oxazoles: 89
      - Oxadiazoles: 146
        4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine: 1
  - Pyridines: 88
    - 4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine: 1

Experts

1.	Baeza, Isabel: 1 article (06/2015)
2.	Barrios-Payán, Jorge: 1 article (06/2015)
3.	Bini, Estela Isabel: 1 article (06/2015)
4.	Hernández-Pando, Rogelio: 1 article (06/2015)
5.	Marquina, Brenda: 1 article (06/2015)
6.	Mata-Espinosa, Dulce: 1 article (06/2015)
7.	Molina-Salinas, Gloria María: 1 article (06/2015)
8.	Navarrete-Vázquez, Gabriel: 1 article (06/2015)
9.	Ramos-Espinosa, Octavio: 1 article (06/2015)

Related Diseases

1.	Pulmonary Tuberculosis 06/01/2015 - "Therapeutic efficacy of liposomes containing 4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine in a murine model of progressive pulmonary tuberculosis."

Related Drugs and Biologics

1.	Liposomes (Liposome)